Form 4 for LUNG Pulmonx Corp

Accepted 2026-06-03 16:15:48 ET · period of report 2026-06-01 · accession 0001805624-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-06-03 16:15	2026-06-01+	LUNG	French Glendon E. III	Pres, CEO, Dir	S - Sale	$1.55	-56.1K	1.18M	-5%	-$86.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-06-01	S	D	4,171	$1.54	1,230,140	D	—	—	(F1) These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
2	Common	Common Stock	2026-06-01	S	D	38,467	$1.54	1,191,673	D	—	—	(F2) Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
3	Common	Common Stock	2026-06-02	S	D	13,511	$1.57	1,178,162	D	—	—	(F3) Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of June 2, 2025.